PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Disease ReportsType 2 diabetes mellitus
MeSH D003924 - type 2 diabetes mellitus
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D003920:Diabetes mellitus
11 Companies
13 Drugs
$
Success rate
D003924: 
Type 2 diabetes mellitus
104 Companies
40 Drugs
$
Success rate
D003923:Lipoatrophic diabetes mellitus
0 Companies
0 Drugs
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
Accord HealthcareGlimepiride Glimepiride  2007-08-23   
Glipizide Glipizide  1997-09-11   
Pioglitazone Pioglitazone  2013-02-13   
Pioglitazone Pioglitazone Accord  2012-03-21   
Repaglinide Repaglinide Accord  2011-12-22   
Metformin, Sitagliptin Sitagliptin / Metformin Accord  2022-07-22   
Sitagliptin Sitagliptin Accord  2022-04-25   
Metformin, Vildagliptin Vildagliptin / Metformin Accord  2022-03-24   
Ajanta PharmaMetformin Metformin  2020-04-09   
Alkem LaboratoriesColesevelam Colesevelam  2018-10-05   
Metformin Metformin  2010-11-01   
AllerganAcarbose Acarbose  2008-05-07   
ACETOHEXAMIDE Acetohexamide  1987-11-25   
CHLORPROPAMIDE Chlorpropamide  1984-09-24   
Colesevelam Colesevelam  2020-09-02   
Pioglitazone Glidipion (previously Pioglitazone Actavis Group)  2012-03-15   
Glimepiride Glimepiride  2010-04-27   
Glipizide Glipizide  1995-02-27   
Glyburide Glyburide  2002-11-14   
Metformin, Glyburide Glyburide Metformin  2005-06-28   
Metformin Metformin  2002-01-25   
Nateglinide Nateglinide  2011-03-30   
Pioglitazone Pioglitazone Actavis  2012-03-15   
Repaglinide Repaglinide  2014-01-22   
TOLAZAMIDE Tolazamide  1986-08-01   
Tolbutamide Tolbutamide  1982-01-01   
AlraTolbutamide Tolbutamide  1982-01-01   
AlvogenNateglinide Nateglinide  2015-12-11   
Amneal PharmaceuticalsMetformin Metformin  2006-06-05   
Saxagliptin Saxagliptin  2023-07-31   
Amta LaboratoriesMetformin Metformin  2021-08-03   
Andrx CorporationMetformin Fortamet  2004-04-27   
ANI PharmaceuticalsACETOHEXAMIDE Acetohexamide  1987-02-09   
CHLORPROPAMIDE Chlorpropamide  1982-01-01   
Glipizide Glipizide  1996-03-04   
CHLORPROPAMIDE Glucamide  1984-10-11   
Rosiglitazone Rosiglitazone  2013-01-25   
Tolbutamide Tolbutamide  1982-01-01   
1
2
3
4
5
6
...
11
>
Clinical Trials
Historical Success Rate
Phase 1
78%
113/145
Phase 2
69%
137/200
Phase 3
77%
165/215
Approved: 55Overall Success rate: 41%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Allergan
Glyburide,
Metformin,
Metformin glycinate,
Metformin hydrochloride
AstraZeneca
Metformin,
Dapagliflozin,
Exenatide,
Saxagliptin,
Metformin hydrochloride,
Pramlintide,
Metformin glycinate,
Angiotensin ii,
Benzocaine,
Gliclazide,
Enoblituzumab,
Ademetionine,
Tesaglitazar,
Doconexent,
Voglibose,
Tilarginine,
Sodium chloride,
Sodium lactate,
ALVELESTAT,
Aspartame,
Bevifimod,
COTADUTIDE,
Nadide,
Telbermin,
Tiratricol,
VERINURAD,
Insulin,
Microcrystalline cellulose,
Triglycerides, medium-chain,
AZD1656,
Glyclazide,
Lovaza,
Omacor,
Diluent,
Endocrine,
Manitol,
Viaject,
AZD8601,
Epanova,
Glimepirde,
Azd5658,
Lyspro,
Sglt2,
Farxiga,
Gluconorm,
Solumedrol,
Arm1,
Azd6370,
Azd6714,
Rdx5791,
Arm2,
Apelin,
AZD4017,
Azd8329,
Evidence,
Mydfrin
1
2
3
4
5
6
7
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use